Evidence map›Paper›PMID 40897687›Full record

ArticleCell death & disease2025

Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect.

Nuria Vilaplana-Lopera, Jiyoung Kim, Gilyeong Nam, Iain D C Tullis, Salome Paillas, Jia-Ling Ruan, Pei Ju Lee, Yanyan Jiang, Sohee Park, Tianxu Hou and 14 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Reduced corneal toxicity following whole brain irradiation in mice.Clinical and translational radiation oncology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Microenvironmental remodeling in FLASH radiotherapy.Frontiers in cell and developmental biology · 2026
    Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Nuria Vilaplana-Lopera *Department of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3156-9908
Jiyoung Kim *Department of Oncology, University of Oxford, Oxford, UK.
Gilyeong NamDepartment of Radiation Oncology, Severance Hospital, Yonsei University Medical School, Seoul, Republic of Korea.
Iain D C TullisDepartment of Oncology, University of Oxford, Oxford, UK.
Salome PaillasDepartment of Oncology, University of Oxford, Oxford, UK.
Jia-Ling RuanDepartment of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8274-4959
Pei Ju LeeDepartment of Oncology, University of Oxford, Oxford, UK.
Yanyan JiangDepartment of Oncology, University of Oxford, Oxford, UK.
Sohee ParkDepartment of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea.
Tianxu HouDepartment of Oncology, University of Oxford, Oxford, UK.
Ayesha NasirDepartment of Oncology, University of Oxford, Oxford, UK.
Eve CharlesworthDepartment of Oncology, University of Oxford, Oxford, UK.
Ellie WalkerDepartment of Oncology, University of Oxford, Oxford, UK.
Ammar Abu-HalawaDepartment of Oncology, University of Oxford, Oxford, UK.
Mark A HillDepartment of Oncology, University of Oxford, Oxford, UK.
Changhoon ChoiDepartment of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea.
Ik Jae LeeDepartment of Radiation Oncology, Severance Hospital, Yonsei University Medical School, Seoul, Republic of Korea.
Youngtae JeongDepartment of New Biology, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea.ORCID http://orcid.org/0000-0001-6269-8190
Samira Lakhal-LittletonDepartment of Physiology, Anatomy & Genetics, University of Oxford, Oxford, UK.
Chee Kin ThenDepartment of Radiation Oncology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
Shing-Chuan ShenGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Amato J GiacciaDepartment of Oncology, University of Oxford, Oxford, UK.
Kristoffer PeterssonDepartment of Oncology, University of Oxford, Oxford, UK.
Eui Jung MoonDepartment of Oncology, University of Oxford, Oxford, UK. ejung.moon@oncology.ox.ac.uk.ORCID http://orcid.org/0000-0001-7916-7978

Funding

Translational Studies in FLASH Particle RadiotherapyP01CA257904 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Mary E. Putt · 2022 to 2026
$14.2M
Cancer Research UK (CRUK) C6078/A28736NCI NIH HHS P01 CA257904Oxford University | John Fell Fund, University of Oxford (John Fell OUP Research Fund) AND00180RCUK | Medical Research Council (MRC) MC_UU_00001/11RCUK | Medical Research Council (MRC) MR/X006611/1U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 5P01CA257904-03
6 · The paper itself

Abstract

Iron is vital to living cells, playing a key role in cellular respiration, DNA synthesis, and various metabolic functions. Importantly, cancer cells have a higher dependency on iron compared to normal cells to support their rapid growth and survival. Due to this fact, tumors are more vulnerable to ferroptosis, an iron-dependent form of regulated cell death. Radiation therapy (RT), a standard treatment for many cancer patients, is known to induce ferroptosis. Ultra-high dose rate FLASH RT offers an improved therapeutic window by minimizing damage to normal tissues while preserving tumor control. However, the precise biological mechanisms behind the protective effects of FLASH RT on normal tissues remain unclear. In this study, we propose that variations in lipid peroxidation and ferroptosis, driven by intrinsic differences in iron levels between normal and cancerous tissues, contribute to this effect. Our findings show that FLASH RT increases lipid peroxidation and induces ferroptosis in tumor cells but does not significantly elevate lipid peroxidation and ferroptosis in normal tissues compared to conventional RT. To determine whether raising iron levels in normal tissues could abrogate the protective effects of FLASH, mice were fed a high-iron diet before RT. A high-iron diet before and after RT reversed the protective effect of FLASH, resulting in increased intestinal damage and lipid peroxidation. This suggests that baseline iron levels and iron-driven lipid peroxidation are critical factors in mediating the protective outcomes of FLASH RT. Overall, our study sheds light on the role of iron in modulating RT responses and provides new mechanistic insights into how FLASH RT influences normal and cancerous tissues.

Indexed as

IronLipid PeroxidationRadiotherapyAnimalsCell Line, TumorFerroptosisHumansMiceMice, Inbred C57BLNeoplasmsOrgan SpecificityIron

Identifiers

PMID40897687
PMCPMC12405469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.